(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Earnings Reaction Wave: Adobe Dips, eGain Climbs

September 14th, 2023

Adobe Inc. (Nasdaq: ADBE), a prominent software company, reported robust third-quarter fiscal 2023 earnings, with an EPS of $4.09, surpassing the consensus EPS estimate of $3.98. The company's quarterly sales reached $4.89 billion, slightly above ana. Read more

Breaking News: AMC's $325.5M Equity Raise and Draganfly's Defense Orders

September 14th, 2023

AMC Entertainment Holdings, Inc. (NYSE: AMC) said that it successfully raised approximately $325.5 million in new equity capital by selling 40 million shares at an average price of around $8.14 per share, before commissions and fees. $AMC was trad. Read more

Redburn Partners: Carnival and Norwegian Cruise Line are a Buy

September 14th, 2023

Carnival Corporation & plc (NYSE: CCL), a leading cruise line company, has been upgraded by Redburn Partners from Neutral to Buy, along with a price target of $23. With $CCL closing at $15.02 on Wednesday, this price target suggests a potential up. Read more

Semtech Posts Upbeat Results, Outlook Falls Short; FDA Panel Backs Alnylam's Patisiran

September 13th, 2023

Semtech Corporation (Nasdaq: SMTC), a technology company specializing in semiconductor solutions, reported earnings of $0.11 per share for the second quarter of fiscal 2024, surpassing the consensus EPS estimate of $0.02. Quarterly sales for Semtech . Read more

IBEX Misses Estimates, Guides Revenue Below-Consensus

September 13th, 2023

IBEX Limited (Nasdaq: IBEX), a company specializing in customer support solutions, reported earnings of $0.33 per share for the fourth quarter of fiscal 2023. This figure fell short of the consensus EPS estimate of $0.49. Quarterly sales for IBEX amo. Read more

REV Group Beats Estimates; Bullish View On Immunocore

September 13th, 2023

REV Group, Inc. (NYSE: REVG) exceeded expectations in its third-quarter fiscal 2023 earnings report, posting adjusted earnings of $0.35 per share compared to the consensus EPS estimate of $0.23. The company also outperformed in terms of quarterly sal. Read more

Spirit Airlines Lowers Outlook; Alnylam Stock Halted Amid FDA Panel Review

September 13th, 2023

Shares of Spirit Airlines, Inc. (NYSE: SAVE) experienced a dip in pre-market trading as it revised downwardly its third-quarter 2023 outlook. The company now anticipates revenues between $1.245 billion and $1.255 billion, a notable decrease from its . Read more

Momentum Builds: Workhorse's IRS Determination; Edgio's Upbeat Q2 Results

September 13th, 2023

Shares of Workhorse Group Inc. (Nasdaq: WKHS) soared over 20% in after-hours trading following the company's announcement of IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit. This approval opens the door for Workhorse . Read more

InnovAge Posts Mixed Results; Lockheed Martin Bags $841.4M+ Contract Modification

September 12th, 2023

InnovAge Holding Corp. (Nasdaq: INNV), a healthcare company, posted a fourth-quarter fiscal 2023 loss of $(0.09) per share, falling short of the consensus estimate loss of $(0.03). Nevertheless, the company reported quarterly sales of $176.87 million. Read more

Breaking: Asset Sale Deal Ignites Avalo Therapeutics

September 12th, 2023

Shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) surged by more than 40% following the company's announcement of a purchase agreement with AUG Therapeutics, LLC (AUG), wherein it will sell its rights, assets, and interests related to the 800 Series . Read more